News

The Clinical and Translational Science Institute (CTSI) offers Spark Awards, previously known as vouchers, to researchers who need to jump-start their research. The goal of the Spark Award is to support preliminary work and generate essential data for both new and ongoing projects. The CTSI is proud to highlight how Spark Award recipients are utilizing their funding.

As the landscape of federal data availability continues to evolve, we recognize the need for investigators and teams to have access to alternative sources of information and data.

The Clinical and Translational Science Institute (CTSI) offers Spark Awards, previously known as vouchers, to researchers who need to jump-start their research. The goal of the Spark Award is to support preliminary work and generate essential data for both new and ongoing projects. The CTSI is excited to highlight how Spark Award recipients are utilizing their funding.

Julie Johnson, PharmD, director of The Ohio State University Clinical and Translational Science Institute (CTSI) has been selected to join a group of government, academia and industry stakeholders working together to identify critical issues in, and inspire action toward improving, the system of drug discovery, development and translation.

The Microbiome Informatics Webinar Series kicks off Tuesday, February 25, 2025, with Dr. Tom Delmont, a leading expert in microbial ecology and metagenomics. He will be diving into Anvi'o, a powerful open-source platform for microbiome data visualization and analysis.

We are pleased to announce that Dr. Amy Margolis has joined the Clinical and Translational Science Institute (CTSI) as the Co-Director of Workforce Development and Director of the Investigator Career Development and Training Program.

Dr. Amy Margolis is Professor of Psychiatry and Behavioral Health at The Ohio State University. She specializes in developmental cognitive neuroscience, focusing on how environmental factors influence brain development. Dr. Margolis leads groundbreaking research exploring the impact of prenatal chemical and social exposures on cognitive development in children, aiming to uncover mechanisms that may inform interventions for learning disorders as well as other mental health problems.

Dr. Margolis brings over a decade of comprehensive knowledge, practical experience and a deep dedication to mentoring and developing the next generation of research scientists. Many of the graduate students, postdoctoral fellows and junior faculty she has mentored have gone on to successful careers as scientists in academia, government and industry. Dr. Margolis passionately believes that by creating safe places for dialogue, and infrastructure support, we can empower and engage people from historically excluded groups in the clinical and translational science workforce and in research studies.

In her new role at the CTSI, Dr. Margolis will collaborate with institutional leadership to further develop innovative programming, grant-writing resources and educational opportunities that facilitate the success of clinical and translational investigators. Dr. Margolis's interdisciplinary and collaborative approach will be an asset to the CTSI. She envisions developing new programming to complement existing initiatives, ranging from a High School STEM writing program aimed at fostering a diverse next generation of scientists to supporting mid-career faculty in the transition to full Professor .

Dr. Margolis's expertise, passion and dedication will greatly contribute to the mission of the CTSI and the advancement of today’s discoveries to improve health for all. Please join us in welcoming Dr. Amy Margolis.

Liz Klein Ph.D, MPH, Ohio State CTSI leadership member, co-authored a recent study that found that quitline coaching significantly helped young adults who vape quit.

 This initiative provides training opportunities at both NCATS and FDA.

Due to the size and complexity of Ohio State’s portfolio of more than 7000 active IRB studies, the transition from Buck-IRB to Huron will occur in phases.